Next Article in Journal
Hookah (Shisha, Narghile) Smoking and Environmental Tobacco Smoke (ETS). A Critical Review of the Relevant Literature and the Public Health Consequences
Next Article in Special Issue
Antecedents and Covariates of Alcohol Consumption among Swiss Male Conscripts
Previous Article in Journal
Valuing Climate Change Impacts on Human Health: Empirical Evidence from the Literature
Previous Article in Special Issue
Bloodborne Viral Hepatitis Infections among Drug Users: The Role of Vaccination
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2009, 6(2), 787-797;

Attitudes toward Methadone among Out-of-Treatment Minority Injection Drug Users: Implications for Health Disparities

The Miriam Hospital, 164 Summit Ave., Providence, RI 02906, USA
Alpert Medical School, Brown University, Providence, RI 02912, USA
Center for Prisoner Health and Human Rights, The Miriam Hospital, Providence, RI 02906, USA
MAP Behavioral Health Services (MAP Outreach Program), 324 Elmwood Ave., Providence, RI 02907, USA
Author to whom correspondence should be addressed.
Received: 1 February 2009 / Accepted: 18 February 2009 / Published: 23 February 2009
(This article belongs to the Special Issue Drug Abuse and Addiction)
Full-Text   |   PDF [183 KB, uploaded 19 June 2014]


Injection drug use (IDU) continues to be a significant public health issue in the U.S. and internationally, and there is evidence to suggest that the burden of injection drug use and associatedmorbidity and mortality falls disproportionately on minority communities. IDU is responsible for a significant portion of new and existing HIV/AIDS cases in many parts of the world. In the U.S., the prevalence of HIV and hepatitis C virus is higher among populations of African-American and Latino injection drug users (IDUs) than among white IDUs. Methadone maintenance therapy (MMT) has been demonstrated to effectively reduce opiate use, HIV risk behaviors and transmission, general mortality and criminal behavior, but opiate-dependent minorities are less likely to access MMT than whites. A better understanding of the obstacles minority IDUs face accessing treatment is needed to engage racial and ethnic disparities in IDU as well as drug-related morbidity and mortality. In this study, we explore knowledge, attitudes and beliefs about methadone among 53 out-of-treatment Latino and African-American IDUs in Providence, RI. Our findings suggest that negative perceptions of methadone persist among racial and ethnic minority IDUs in Providence, including beliefs that methadone is detrimental to health and that people should attempt to discontinue methadone treatment. Additional potential obstacles to entering methadone therapy include cost and the difficulty of regularly attending a methadone clinic as well as the belief that an individual on MMT is not abstinent from drugs. Substance use researchers and treatment professionals should engage minority communities, particularly Latino communities, in order to better understand the treatment needs of a diverse population, develop culturally appropriate MMT programs, and raise awareness of the benefits of MMT. View Full-Text
Keywords: Injection drug use; methadone; health disparities; HIV/AIDS Injection drug use; methadone; health disparities; HIV/AIDS
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Zaller, N.D.; Bazazi, A.R.; Velazquez, L.; Rich, J.D. Attitudes toward Methadone among Out-of-Treatment Minority Injection Drug Users: Implications for Health Disparities. Int. J. Environ. Res. Public Health 2009, 6, 787-797.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top